Today news
The same in other media
SEC recommends Zydus Cadila's three-dose covid-19 vaccine for emergency use
Reading now: 721
vaccine, ZyCoV-D, an official told Mint. “The ZyCoV-D vaccine has been recommended for approval on Thursday during the meeting," the official said.
The drugmaker has also evaluated a two-dose regimen for ZyCoV-D vaccine using a 3 mg dose per visit and the immunogenicity results had been found to be equivalent to the current three-dose regimen. "We have also asked the company to submit additional data for the 2-dose regimen of its vaccine," the official said.
The SEC is, however, evaluating the data already submitted by the company and is likely to give final approval. The Ahmedabad-based pharmaceutical firm had applied to the Drug Controller General of India (DCGI) for EUA for its three-dose ZyCoV-D, its plasmid DNA vaccine against
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
COVID-19
United States
|
Cases: 46 252 513
Deaths: 750 423
Recovered: 0
|
India
|
Cases: 34 321 025
Deaths: 459 652
Recovered: 0
|
Brazil
|
Cases: 21 835 785
Deaths: 608 235
Recovered: 0
|
United Kingdom
|
Cases: 9 215 683
Deaths: 141 607
Recovered: 0
|
Russia
|
Cases: 8 494 589
Deaths: 237 619
Recovered: 0
|